CRBP - CIK 0001595097
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported revenue of $0.00 for fiscal year 2022, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2022 | $0.00 | -100.0% |
| FY 2021 | $881.71K | -77.6% |
| FY 2020 | $3.94M | -89.1% |
| FY 2019 | $36.14M | +649.5% |
| FY 2018 | $4.82M | +97.6% |
| FY 2017 | $2.44M | +27.7% |
| FY 2016 | $1.91M | +194.8% |
| FY 2015 | $648.38K | - |
Between fiscal 2015 and fiscal 2022, Corbus Pharmaceuticals Holdings, Inc.'s revenue declined from $648.38K to $0.00.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.